ArticleFrontiers in immunology2024
Case report: A highly active refractory myasthenia gravis with treatment of telitacicept combined with efgartigimod.
Chaoyue Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this paperpooled itcites it